Abbott Laboratories 2014 Annual Report Download - page 25

Download and view the complete annual report

Please find page 25 of the 2014 Abbott Laboratories annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 80

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80

23
ABBOTT 2014 ANNUAL REPORT
2014 SALES BY DIVISION (in billions)
GROWTH DRIVER VASCULAR
2012 2018
$1.2 billion
$2.0 billion
(estimated)
CATARACT SURGICAL SYSTEMS
AND LENSES
VISION CARE VASCULAR DEVICES
BREAKTHROUGH IN DIABETES MONITORING
FREESTYLE
LIBRE
With the launch of
this next-generation
technology, Abbott
created an entirely
new category, Flash
Glucose Monitoring,
eliminating the need
for routine finger pricks
Projected Growth in Market for Interventional Treatment
of Superficial Femoral Artery (Upper Leg)
Our Supera stent, launched in the United States, helps restore
blood flow through blockages in the upper legs
DIABETES CARE
VISION
$1.22
DIABETES
$1.19
#2 Abbott is the fastest-
growing company in the
premium lens segment
VASCULAR
$2.98